COMPETE Act

HR8082, titled the "Competition and Openness in Markets to Promote Efficiency, Transparency, and Enhanced affordability Act" or "COMPETE Act," was introduced in the House of Representatives on March 25, 2026. It was subsequently referred to the House Committee on Energy and Commerce on the same day. The bill's primary objective is to amend Section 2791(b) of the Public Health Service Act to provide a specific definition for "short-term limited duration insurance." This definition includes plans with an expiration date not exceeding 12 months after the original effective date and allows for renewal guarantees without additional underwriting. The bill does not authorize or appropriate any specific funding amounts. Its mechanism is regulatory, aiming to clarify and potentially expand the availability or structure of short-term limited duration health insurance products. This legislative action could influence the competitive landscape within the health insurance sector by providing a clearer framework for these types of plans. Companies operating in the health insurance market that offer or could offer such products would be directly affected by this regulatory clarification. Structural winners, should this bill progress and become law, would be health insurance issuers that specialize in or are looking to expand into the short-term limited duration insurance market, as the bill provides a defined legal framework for these products. Conversely, traditional comprehensive health insurance providers might face increased competition from these more flexible, albeit limited, plans. Given the early stage of the bill, specific company impacts are not yet quantifiable, and no direct market data is provided to assess current stock movements. The bill has only been introduced and referred to committee, indicating a long legislative path ahead, including potential committee hearings, markups, and votes in both chambers. No specific companies or tickers are named as direct beneficiaries or losers at this early stage, as the impact would be broad across the health insurance industry rather than concentrated in a few entities. The bill's focus is on defining a product type, which could affect the entire market segment.